title: [The antipsychotic drug aripiprazole (ABILIFY)].
authors.affiliation: t_hirose@research.otsuka.co.jp
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Hirose
authors.forename: Noriyuki
authors.initials: N
authors.lastname: Mamiya
authors.forename: Sakiko
authors.initials: S
authors.lastname: Yamada
authors.forename: Masaru
authors.initials: M
authors.lastname: Taguchi
authors.forename: Teruchika
authors.initials: T
authors.lastname: Kameya
authors.forename: Tetsuro
authors.initials: T
authors.lastname: Kikuchi
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D000068180:Aripiprazole; D002986:Clinical Trials as Topic; D006801:Humans; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use*; D015363:Quinolones / Q000494:pharmacology / Q000627:therapeutic use*; D017448:Receptors, Dopamine D2 / Q000819:agonists* / Q000502:physiology; D012559:Schizophrenia / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D017448:Receptors, Dopamine D2; D000068180:Aripiprazole